Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on June 1, 2021. The report details a material definitive agreement involving the sale of a subsidiary's equity interests.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of all equity interests in Windset Holdings 2010 Ltd. ("Windset") by Curation Foods, Inc. (a wholly owned subsidiary of Landec).
- Purchase Price: Aggregate of $45.1 million.
- Net Proceeds: Approximately $41.2 million.
- Use of Proceeds: Full repayment of borrowings under the Company's credit and guaranty agreement with Goldman Sachs Specialty Lending Group, L.P. and affiliates of Guggenheim Credit Services, LLC.
- Future Consideration: Curation Foods retained rights to additional purchase price consideration contingent on certain transactions or equity issuances involving Windset until September 2022.
Material Changes
The primary material change is the divestiture of the Windset asset and the concurrent reduction of corporate debt. The filing does not provide comparative financial metrics (revenue, profit, margins) for the period, as this is a current report focused on a specific transaction rather than periodic financial results.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard transactional representations. The document notes that representations and warranties in the Purchase Agreement were made solely for the benefit of the parties to allocate risk and may not be statements of fact.
Investor Verification Checklist
- Verify the exact terms of the "additional purchase price consideration" retained by Curation Foods until September 2022.
- Confirm the full text of the Share Purchase Agreement (Exhibit 10.1) for customary covenants and conditions.
- Review the press release (Exhibit 99.1) for any additional strategic context regarding the sale.
- Note that the registrant is Landec Corporation (LNDC), not Lifecore Biomedical, Inc.